UNSPSC 51113503: Venetoclax

Venetoclax is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).

UNSPSC 51113503 Venetoclax is a Commodity code that represents a single pharmaceutical product — a targeted cancer therapy used in hematologic malignancies. State and local governments procure venetoclax almost exclusively through health systems, county health departments, and public hospitals that deliver oncology care to uninsured or underinsured populations. The recent opportunities block contains no active solicitations for venetoclax itself. Instead, the indexed opportunities span a wide range of unrelated pharmaceutical and medical services — oxygen cylinder rental, naloxone and drug deactivation systems for opioid response, basic and advanced life support medications and supplies for fire departments, and forensic drug reference standards — none of which are venetoclax or specialty oncology therapeutics. The mismatch between the code's nominal scope and the actual opportunities signals that this code sees little relevant activity in the state and local procurement space at present.

State and local government procurement of specialized cancer therapeutics like venetoclax typically routes through established GPOs (group purchasing organizations), standing pharmaceutical contracts at public health systems, or Medicaid managed-care carve-outs rather than through discrete RFP or IFB notices. The lack of recent solicitations bearing this code does not indicate zero demand — public hospitals and county health systems in high-need areas with significant Medicaid or uncompensated-care populations do procure these drugs — but rather that procurement occurs through established frameworks and cooperative agreements that do not appear as standalone opportunities in the state and local notice stream. Firms pursuing venetoclax sales to state and local health systems should focus on direct outreach to oncology procurement officers at large public hospital systems and state Medicaid programs rather than on monitoring RFP activity under this code.